|
|||||
|
|
REMOVED: MiR-539-3p inhibits osteoblast activity and bone formation in vivo via targeting LRP-6 |
|
| Affiliation: | 1. CSIR- Central Drug Research Institute;2. Department of Medicine School of Rheumatology University of Massachusetts Medical School |
| Abstract: | |
| Keywords: | |
| 本文献已被 ScienceDirect 等数据库收录！ | |